Third Affiliated Hospital, Sun Yat-Sen University clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 133 studies whose lead sponsor is Third Affiliated Hospital, Sun Yat-Sen University. 35 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 5, 2026.
Keep track of what changes. Save the Third Affiliated Hospital, Sun Yat-Sen University studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- China
- 108
Focus areas
Conditions Third Affiliated Hospital, Sun Yat-Sen University leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 133. Browse all 133 →
- Clinical Evaluation of a Novel DAB Chromogenic Tissue-Based Assay for Detecting Anti-GABABR AntibodiesNot yet recruitingNCT07858175
- Very Low-volume Plasma Exchange in ACLFNot yet recruitingNCT07857434Not applicable
- Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and SepsisRecruitingNCT06562803Not applicable
- Cohort Study on Neuroimmune Diseases in the Reproductive AgeRecruitingNCT07653984
- Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 TrialNot yet recruitingNCT07543783Phase 2
- Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular CarcinomaNot yet recruitingNCT07543510Not applicable
- Hospital-Based Management of Patients With Chronic Hepatitis B Virus InfectionRecruitingNCT06966908
- Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) LevelsRecruitingNCT07353216
- Effectiveness of a Virtual Health Management Community (VHMC) for Pre-diabetes in ChinaNot yet recruitingNCT07338552Not applicable
- Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular CarcinomaNot yet recruitingNCT07281664Not applicable
- Treatment of Spinal Cord Injury Using Autologous Concentrated Growth FactorsNot yet recruitingNCT07253233Early Phase 1
- Peginterferon Treatment Study for Inactive Chronic Hepatitis B PatientsRecruitingNCT05182463Phase 4
- Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum DisorderRecruitingNCT06763848Not applicable
- MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver TransplantationNot yet recruitingNCT06825572Phase 1
- TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTTRecruitingNCT05984511Not applicable
- Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLFRecruitingNCT03920618Not applicable
- Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCCRecruitingNCT05484908Not applicable
- Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLFRecruitingNCT04597164
- Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis bRecruitingNCT02883647
- Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver FailureRecruitingNCT04310787
- Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic CholangiocarcinomaNot yet recruitingNCT06567600Phase 2
- A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves OrbitopathyNot yet recruitingNCT06510114Phase 4
- Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in ChinaRecruitingNCT06081231
- PRevention of OsTEoporotiC FracTure 2 Pilot StudyRecruitingNCT06134908Not applicable
- Two-dimensional Shear Wave Elastography for Assessment of Cirrhosis and Portal HypertensionNot yet recruitingNCT06358092
- Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.RecruitingNCT04231565Not applicable
- HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.RecruitingNCT04640129Phase 4
- Individual Nutrition Support in HBV-ACLF Patients at Nutrition RiskRecruitingNCT06128421Not applicable
- The Therapeutic Effect of Different Exercise Intensities on Weight Loss in Obese ChildrenNot yet recruitingNCT06205563Not applicable
- TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCCRecruitingNCT05250843Phase 2/3
- Multifaceted Comparison of Ultrasound-guided Ablation and Laparoscopic Adrenalectomy for Aldosterone-producing AdenomaRecruitingNCT05991856
- Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in ChinaRecruitingNCT05726461Not applicable
- MIS-D Versus MIS-TLIF for the Treatment of Lumbar Spinal StenosisNot yet recruitingNCT04318795Not applicable
- Oral Vitamin D Treatment for the Prevention of Hepatocellular CarcinomaNot yet recruitingNCT02779465Phase 4
- Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different RegimensRecruitingNCT02587741Early Phase 1
- Maternal Oral Microbiota and Immune Signatures Associated With Spontaneous Labor OnsetCompletedNCT07839364
- Clinical Characteristics of RecompensationActive, not recruitingNCT07651683
- PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver FailureActive, not recruitingNCT07409259Early Phase 1
- Establishing a Virtual Health Community Management Model for Pre-Diabetes PatientsCompletedNCT07354997Not applicable
- 2025 Hypoglycemia Early-Warning and Physician-Nurse Collaborative Management Trial in Type 2 DiabetesCompletedNCT07314749Not applicable
- Efficacy and Safety of an Intelligent Insulin-Dosing Decision Support System for Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled StudyCompletedNCT07291804Not applicable
- Origin of the Neonatal Gut Microbiota and Probiotic InterventionCompletedNCT06241222Not applicable
- Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver FailureActive, not recruitingNCT06996392Phase 1
- The Clinical Cure Project of Chronic Hepatitis B in ChinaActive, not recruitingNCT04035837Phase 4
- Study of the Correlation Between Donor CIRBP and Transplanted Kidney FunctionCompletedNCT06641622
- Explainable Machine Learning for the Assessment of Donor Grafts in Liver TransplantationCompletedNCT06535217
- Clinical Application of Intrapartum UltrasoundCompletedNCT06442735Not applicable
- Systemic Inflammation in Liver CirrhosisCompletedNCT04850534
- MSC-EV in Acute-on-Chronic Liver Failure After Liver TransplantationWithdrawnNCT05881668Phase 1
- The Safety and Efficacy of MSC-EVs in Acute/Acute-on-Chronic Liver FailureWithdrawnNCT05940610Phase 1/2